IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2019 Holdings

Filed 2019-11-14 | 12 holdings | $150.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc.(BIIB)COM09062X103$149.7M643,00099.5%
Medicines Co.COM584688105$210.1K4,202,0000.1%
Allergan PLCSHSG0177J108$175.4K1,042,5000.1%
Ironwood Pharmaceuticals Inc.(IRWD)COM CL A46333X108$86.7K10,103,0000.1%
Abbvie Inc.(ABBV)COM00287Y109$75.0K1,0000.0%
Innoviva Inc.(INVA)COM45781M101$65.8K6,242,0000.0%
Intercept Pharmaceuticals Inc.(ICPTUSD)COM45845P108$56.5K851,0000.0%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$31.0K242,0000.0%
Puma Biotechnology Inc.(PBYI)COM74587V107$15.3K1,417,0000.0%
Mersana Therapeutics Inc.COM59045L106$5.9K3,750,0000.0%
Regulus Therapeutics IncCOM NEW75915K200$1.3K1,851,8510.0%
Mirati Therapeutics Inc.(MRTXEUR)COM60468T105$771,0000.0%